Researchers discovered that PTSD may be driven by excess GABA from astrocytes, not neurons. This chemical imbalance disrupts ...

Russia's Gamaleya Center is set to commence human trials for a groundbreaking personalized mRNA melanoma vaccine, potentially revolutionizing cancer treatment.

Pre-clinical trials of the Cancer Vaccine showed promising results in halting tumor growth and spread. The human trials will ...

Canine and human cancers bear many similarities — studies in dogs are helping to develop treatments for both species.

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

A Senate committee rejected Trump's proposed 40% cut to NIH funding. Philadelphia's medical research community says it means ...

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have ...

Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of ...